Superspreading ideas

One of the interesting side effects of writing about both science and business is that concepts described for one subject often meld or twist into ideas in the other.
| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00
One of the interesting side effects of writing about both science and business is that concepts described for one subject often meld or twist into ideas in the other. Such was the case recently while I was reading a paper in Nature on the role of superspreading events (SSEs) in infectious disease transmission. The basic premise is that the transmission of conditions like SARS or measles may rely more on events punctuated by specific individuals than on a homogeneous spread throughout a population. These "Typhoid Mary's" trigger SSEs, whereby large numbers of people are infected from localized interactions.
Continue reading below...
A black mosquito is shown on pink human skin against a blurred green backdrop.
InfographicsDiscovering deeper insights into malaria research
Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Read More
Without describing all of the statistical parameters involved, history seems to bear out the theory, with startling implications for the control of future outbreaks. Aside from this realization, however, was the bizarre parallel that formed in my mind between the implications described by the authors about infectious disease and the lessons propagated by hundreds of business writers about best practices.
For several years, I have dedicated increasing amounts of time to business books and magazines that tout the latest and greatest ideas for running a successful enterprise. Each book describes highly successful methods that have been developed by highly successful companies, and suggest that if you just follow these simple rules, you too can be a budding GE, IBM, or Novartis.
In this sense, the authors (or their subjects) are the Typhoid Mary's of the business world; they are the superspreaders of ideas.
I don't mean to imply that the business acumen found in these books will lead to hundreds or thousands of deaths. Rather I question how relevant most of these business practices are in the general populace. How many companies actually saw the benefits touted by Six Sigma? How many of us have learned to really influence people? Have only the lactose-intolerant benefited from having someone move their cheese?
Continue reading below...
A white, pink, and blue 3D molecular structure of a simple sugar is shown against a light purple background.
WebinarsAdding a little sugar: what glycomics can bring to medicine
Discover how glycoscience is transforming how scientists understand diseases and opening new doors for drug discovery.
Read More
The problem I have with most of these books is that they promise universal truths without explaining how anything works and perhaps more importantly, where it won't work. So rarely are there follow-up volumes describing practical failures based on faulty philosophies. There are exceptions to this rule, of course, which is part of the reason I own not only Clayton Christensen's Innovator's Dilemma, but also his Innovator's Solution and Seeing What's Next.
In business, as in medicine, too many people are unwilling to do the legwork required to find out what really does or does not work in a situation. Instead, they want to provide and apply sweeping generalizations in the hope that if you throw enough stuff at the wall, some of it will stick. Similarly, while everyone knows that medicine and business are fraught with failure, we are only willing to publish the successes. This is too bad, because in my own life, I have learned more from my failures than from my successes; lessons that have stood the test of time.
Continue reading below...
An illustration of various colored microbes, including bacteria and viruses
WebinarsCombatting multidrug-resistant bacterial infections
Organic molecules with novel biological properties offer new ways to eliminate multidrug-resistant bacteria.
Read More
As the scientists studying infectious diseases postulated, what works for selected individuals may not work for the overall population. In their case, it means focusing more treatment and preventative efforts on the superspreaders of disease. In our case, it may simply mean taking the superspreaders of business acumen with a grain of salt and dose of common sense.

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Close-up of a researcher using a stylus to draw or interact with digital molecular structures on a blue scientific interface.
When molecules outgrow the limits of sketches and strings, researchers need a new way to describe and communicate them.
Portrait of Scott Weitze, Vice President of Research and Technical Standards at My Green Lab, beside text that reads “Tell us what you know: Bringing sustainability into scientific research,” with the My Green Lab logo.
Laboratories account for a surprising share of global emissions and plastic waste, making sustainability a priority for modern research.
3D illustration of RNA molecules on a gradient blue background.
With diverse emerging modalities and innovative delivery strategies, RNA therapeutics are tackling complex diseases and unmet medical needs.
Drug Discovery News September 2025 Issue
Latest IssueVolume 21 • Issue 3 • September 2025

September 2025

September 2025 Issue

Explore this issue